ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th

Rhea-AI Summary

ANI Pharmaceuticals (NASDAQ:ANIP) announced its participation in the upcoming Leerink Partners Therapeutics Forum, focusing on I&I and Metabolism. The company's President and CEO, Nikhil Lalwani, will be conducting one-on-one meetings with investors during the event, which takes place on July 8, 2025, in Boston, MA.

News Market Reaction

+2.61%

1 alert

+2.61% News Effect

On the day this news was published, ANIP gained 2.61%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host 1x1 meetings at the Leerink Partners Therapeutics Forum: I&I and Metabolism on Tuesday, July 8, 2025, in Boston, MA.

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When is ANI Pharmaceuticals (ANIP) participating in the Leerink Partners Therapeutics Forum?

ANI Pharmaceuticals will participate on Tuesday, July 8, 2025 in Boston, MA.

Who will represent ANI Pharmaceuticals at the Leerink Partners Forum?

Nikhil Lalwani, President and Chief Executive Officer of ANI Pharmaceuticals, will represent the company.

What type of meetings will ANI Pharmaceuticals conduct at the Leerink Partners Forum?

The company will host one-on-one meetings with investors at the forum.

What is the focus of the Leerink Partners Therapeutics Forum where ANIP will participate?

The forum focuses on I&I (Immunology & Inflammation) and Metabolism therapeutics.